Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Wendell Jones, Ph.D.
Principal Bioinformaticist and Scientific Advisor
Dr. Jones is currently Principal Bioinformaticist and Scientific Advisor at Q2 Solutions | EA Genomics. He conducts collaborative scientific research with clients in multiple areas, especially in oncology and immuno-oncology. His background includes leading the analysis, development and validation of the bioinformatic and computational systems that process complex genomic assays, including next generation sequencing assays, evaluating new and emerging genomic technologies, and developing bioinformatic implementation strategies. He consults with clients and provides thought leadership in industry and public consortiums involved in genomic science and measurement. Dr. Jones serves on the Board of Directors of the new MAQC Society and is currently participating in the U.S. Food and Drug Administration (FDA)-led Sequencing Quality Control 2 (SEQC2) consortium which is investigating best-practice methods for variant calling in DNA sequencing studies.  Dr. Jones previously had leadership roles in the MAQC, MAQC-II, and SEQC consortiums.

Dr. Jones has over 15 years of experience in advanced genomic technologies and 20 years of experience in scientific and technology leadership positions, including serving as Vice President of Statistics and Bioinformatics at Expression Analysis, Inc (EA) and Chief Science Officer at Reliametrics, a Nortel Networks business unit. He has authored over 40 peer-reviewed publications and has presented at numerous scientific meetings and industry conferences and consortium workshops. Dr. Jones also serves as Adjunct Assistant Professor in the School of Medicine (Dept. of Pathology and Laboratory Medicine) at the University of North Carolina at Chapel Hill.

Related Services: